Arthur P. Bollon
Directeur Général chez Vitruvian BioMedical, Inc.
Profil
Arthur P.
Bollon was the founder of Biogress LLC (founded in 2003), Wadley Biosciences, Inc. (founded in 1987), Cytoclonal Pharmaceutics, Inc. (founded in 1992), and Vitruvian BioMedical, Inc. (founded in 2011) where he held the titles of Chairman & Chief Executive Officer.
He is currently an Independent Director at SignPath Pharma, Inc. (since 2008).
Dr. Bollon's former positions include President & Chief Executive Officer at Hemobiotech, Inc. (2003-2010) and Director at Immunotech Laboratories, Inc. He holds a doctorate degree from The Waksman Institute of Microbiology.
Postes actifs de Arthur P. Bollon
| Sociétés | Poste | Début |
|---|---|---|
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Directeur/Membre du Conseil | 28/05/2008 |
Vitruvian BioMedical, Inc.
 Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Directeur Général | 01/01/2011 |
Anciens postes connus de Arthur P. Bollon
| Sociétés | Poste | Fin |
|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Directeur Général | 01/08/2010 |
| Cytoclonal Pharmaceutics, Inc. | Directeur Général | 01/01/2000 |
| Wadley Biosciences, Inc. | Directeur Général | 01/01/1991 |
| IMMUNOTECH LABORATORIES, INC. | Directeur/Membre du Conseil | - |
| Biogress LLC | Fondateur | - |
Formation de Arthur P. Bollon
| The Waksman Institute of Microbiology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOTECH LABORATORIES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |
| Biogress LLC | |
| Wadley Biosciences, Inc. | |
| Cytoclonal Pharmaceutics, Inc. | Health Technology |
Vitruvian BioMedical, Inc.
Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Commercial Services |
